CMV Seroconversion During Prolonged Prophylaxis With Valgancyclovir in D+/R- Kidney Transplant Recipients Prevents CMV Disease: Long-Term Follow-Up.
Staeck, O., Halleck, F., Rissling, O., Naik, M., Neumayer, H., Budde, K., Khadzhynov, D.Volume:
98
Journal:
Transplantation
DOI:
10.1097/00007890-201407151-02611
Date:
July, 2014
File:
PDF, 228 KB
2014